Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: abdominal pain major surgical or invasive procedure: ivc filter, tracheostomy and percutaneous gastrostomy tube placement history of present illness: ms. is a 65 f who was transferred hospital with gallstone pancreatitis. the patient reports that the pain began at 11am with nausea and small bouts of comitting. the patient denies alcohol use. she reports that at the time of admission, her abdominal pain has improved past medical history: htn, dm, dvt , hyperlipidemia, anxiety, pshx: d&c social history: the patient denies alcohol use. she is married by separated from her husband who is an alcoholic and banned from her housing complex. she also denies tobacco, drug use. she lives independently. family history: noncontributory physical exam: on admission: 97.1 80-120 st 140/60 16 97% aaox3 tachycardic, regular rhythm cta b/l + bc, spigastric tenderness, - sign mild abdominal dilation dre: guiac neg, nl tome no c/c/e pertinent results: 09:37pm blood wbc-26.7* rbc-5.11 hgb-14.0 hct-43.8 mcv-86 mch-27.4 mchc-32.0 rdw-13.7 plt ct-297 03:12am blood wbc-11.2* rbc-3.43* hgb-9.3* hct-30.1* mcv-88 mch-27.1 mchc-30.9* rdw-16.7* plt ct-981* 09:37pm blood pt-13.0 ptt-26.2 inr(pt)-1.1 03:12am blood pt-13.3 ptt-29.5 inr(pt)-1.1 03:12am blood plt ct-981* 09:37pm blood plt smr-normal plt ct-297 03:12am blood glucose-219* urean-16 creat-0.6 na-145 k-4.5 cl-108 hco3-33* angap-9 09:37pm blood glucose-323* urean-19 creat-1.0 na-144 k-2.9* cl-105 hco3-26 angap-16 01:45am blood alt-23 ast-34 alkphos-295* amylase-52 totbili-0.4 02:44am blood alkphos-229* 09:37pm blood alt-124* ast-102* ld(ldh)-236 alkphos-197* amylase-1494* totbili-2.0* dirbili-1.6* indbili-0.4 01:45am blood lipase-32 09:37pm blood lipase-2211* 03:12am blood calcium-8.9 phos-3.6 mg-2.5 09:37pm blood albumin-3.7 calcium-9.0 phos-2.9 mg-1.5* 12:33am blood caltibc-202* ferritn-155* trf-155* 11:26am blood lactate-0.8 k-4.7 03:31am blood freeca-1.13 : right upper quadrant ultrasound: exam is somewhat limited due to patient body habitus. the liver is unremarkable with no focal lesions. the gallbladder has multiple gallstones, with a large gallstone measuring up to 1.4 cm. there is no wall thickening or pericholecystic fluid to suggest cholecystitis. no son sign was present. the common bile duct is markedly dilated measuring 1.5 cm, and there is central intrahepatic biliary ductal dilatation, raising the possibility of a distal cbd obstruction. the distal cbd and pancreas are not able to be visualized due to overlying bowel gas. the portal vein is patent with anterograde flow. there is no ascites : ercp: ten fluoroscopic spot images obtained during ercp procedure without radiologist present. cholangiogram demonstrates dilated intra- and extra- hepatic bile ducts. there is suggestion of irregularity of the intrahepatic ducts which may be projectional. no filling defect is identified within the opacified biliary tree. the cystic duct is normally opacified. impression: intra- and extra-hepatic biliary dilatation. no filling defect is identified within the biliary tree. : ampullary mucosal biopsy: ampullary mucosa with focal acute inflammation and fibrinopurulent exudates consistent with ulceration. : u/s findings: the study is limited due to patient's body habitus. the liver texture is within normal limits allowing for technique. the gallbladder demonstrates multiple gallstones. there is no gallbladder wall edema or pericholecystic fluid. there is no intra- or extra- hepatic biliary ductal dilatation, and the common duct measures 7 mm. main portal vein is patent with antegrade flow. :ct- 1. extensive severe pancreatitis with diffuse enlargement of the pancreas and fat stranding and ongoing formation of peripancreatic fluid collection/pseudocyst with attenuated smv. diffuse peritoneal fat stranding suggestive of panperitonitis with bowel dilatation. 2. cholelithiasis. 3. small ascites, slightly decreased in the lower pelvis. 4. diffuse anasarca. 5. diverticulosis. 6. post g-tube placement. 7. new pneumomediastinum within the pericardial fat along the pericardium, of unknown etiology. clinical correlation with recent procedure and interventions is recommended. brief hospital course: on transfer to , ms. was admitted to the trauma service and transferred to the sicu for further evaluation. she was made npo, with ivf and a foley was placed; the patient refused an ngt at the time. the patient's pain was to be controlled, and the patient was consented for an ercp. the patient received subcutaneous heparin for dvt prophylaxis, her hematocrit was watched on a dialy basis, ad the patient was put on an insulin sliding scale. the patient was 3 at admission. a ruq ultrasound was performed revealing cholelithiasis without cholecystitis, and cbd dilation as well. on , the patient underwent an ercp with sphincterotomy; the report read "intra- and extra-hepatic biliary dilatation. no filling defect is identified within the biliary." her post procedure course was complicated by increased secretions, and hypoxia to 78%; the patient was made aware of the risk of aspiration pneumonia and respiratory distress, but she refused both an ngt and intubation at the time. the patient was made comfortable with anti-anxiety and pain medications, and her vital signs were closely monitored. the patient required fluid bolusing for volume depletion. a geriatric consult was called for further treatment and evaluation while the patient was in the icu as the patient became delirious and had been quite agitated despite lorazepam and haldol. geriatrics recommended low dose dilaudid for pain control prn, altering the dose of haldol, removing all unneccessary tubes, lines and drains, and getting the patinet on a better sleep cycle. on , the patient became tachypneic to a respiratory rate in the 30s, oxygen saturation of 82% on ra, and was put on a face tent as she was not tolerating other oxygen supplementation. the patient's vital signs were unstable, and the patient was combative and aggressive. her mental status began deteriorating, and the patient required intubation for airway protection, and adequate sedation for safety during hospital treatment. the patient was started on unasyn for pneumonia (aspiration). on , the patient was intermittently tachycardic with decreased urine output; she was bolused for presumed volume depletion; her urine output improved and her renal function remained within normal limits. the patient also had an ogt and subsequently a dobhoff tube placed for tube feeds. the patient's respiratory status was frequently monitored and changed according to evaluations. her sedation and ventilation were attempted to be weaned. her hospital course was complicated by post-procedure fevers; blood cultures were sent when the patient spiked, and chest x-rays, urine analysis/cultures were also taken. the patiemt was noted to have a r base consolidation, and went for bronchoalveolar lavage on . the patient was put on vancomycin and later levo as well as zosyn for empiric vap treatment; these antibiotics were stopped when appropriate, i.e, when cultures returned with sensitivities, and/or fevers and leukocytosis decreased. the patient was diuresed when appropriate as she was fluid overloaded with pleural effusions during her hospital stay. a right sided pleural effusion was worsening, and the patient underwent a pleural tap and pigtail placement to expand the lung and rule out empyema as the patient continued to be febrile with some vital sign lability. the patient had stable post procedure anemia until , at which time, the patient had to be transfused 2units of prbcs. as the pt continued to be vent dependednt, the patient underwent a trach, ivc filter, and peg on ; for details please see operative note. om , the patient's trach was inadvertently dislodged, and an emergent trach had to be placed; placement was confirmed by bronch. the patient was discharged to rehab on in stable condition; she was hemodynmically stable, afebrile, tolerating tube feeds, off antibiotics, with normalizing wbc and lfts. medications on admission: glipizide, lipitor, metformin, lisinopril, prilosec discharge medications: 1. heparin (porcine) 5,000 unit/ml solution sig: one (1) injection injection tid (3 times a day). 2. chlorhexidine gluconate 0.12 % mouthwash sig: fifteen (15) ml mucous membrane (2 times a day). 3. docusate sodium 50 mg/5 ml liquid sig: one hundred (100) mg po bid (2 times a day). 4. bisacodyl 10 mg suppository sig: ten (10) mg rectal daily (daily): suppository(s). 5. acetaminophen 160 mg/5 ml solution sig: 325-650 mg po q6h (every 6 hours) as needed for fever. 6. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q4h (every 4 hours) as needed for wheeze. 7. nystatin 100,000 unit/ml suspension sig: five (5) ml po qid (4 times a day) as needed. 8. albuterol sulfate 0.083 % (0.83 mg/ml) solution sig: one (1) neb inhalation q6h (every 6 hours). 9. ipratropium bromide 0.02 % solution sig: one (1) neb inhalation q6h (every 6 hours). 10. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 11. famotidine 20 mg tablet sig: one (1) tablet po bid (2 times a day). 12. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 13. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 14. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day). 15. insulin regular human injection 16. ondansetron hcl (pf) 4 mg/2 ml solution sig: four (4) mg injection q6h (every 6 hours) as needed for n/v. 17. magnesium sulfate 4 % solution sig: sliding scale injection prn (as needed). 18. calcium gluconate 100 mg/ml (10%) solution sig: sliding scale intravenous asdir (as directed). 19. potassium chloride intravenous 20. heparin lock flush (porcine) 100 unit/ml syringe sig: one (1) ml intravenous daily (daily) as needed. 21. potassium phosphate dibasic 3 mmole/ml parenteral solution sig: sliding scale intravenous asdir (as directed). 22. lorazepam 2 mg/ml syringe sig: 0.5-1.0 mg injection q4h (every 4 hours) as needed for agitation. 23. heparin lock flush (porcine) 100 unit/ml syringe sig: one (1) ml intravenous daily (daily) as needed. 24. roxicet 5-325 mg/5 ml solution sig: ml po every hours. 25. aspirin 81 mg tablet sig: one (1) tablet po once a day. discharge disposition: extended care facility: medical center - discharge diagnosis: gallstone pancreatitis discharge condition: stable discharge instructions: please call your doctor or return to the er for any of the following: * you experience new chest pain, pressure, squeezing or tightness. * new or worsening cough or wheezing. * if you are vomiting and cannot keep in fluids or your medications. * you are getting dehydrated due to continued vomiting, diarrhea or other reasons. * signs of dehydration include dry mouth, rapid heartbeat or feeling dizzy or faint when standing. * you see blood or dark/black material when you vomit or have a bowel movement. * your skin, or the whites of your eyes become yellow. * your pain is not improving within 8-12 hours or not gone within 24 hours. call or return immediately if your pain is getting worse or is changing location or moving to your chest or back. * you have shaking chills, or a fever greater than 101.5 (f) degrees or 38(c) degrees. * any serious change in your symptoms, or any new symptoms that concern you. * please resume all regular home medications and take any new meds as ordered. * continue to ambulate several times per day. followup instructions: please follow up with dr. in weeks; make an appointment at procedure: venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more insertion of endotracheal tube interruption of the vena cava enteral infusion of concentrated nutritional substances thoracentesis endoscopic removal of stone(s) from biliary tract endoscopic sphincterotomy and papillotomy percutaneous [endoscopic] gastrostomy [peg] temporary tracheostomy closed [endoscopic] biopsy of bronchus injection of antibiotic transfusion of packed cells replacement of tracheostomy tube insertion of indwelling urinary catheter other closed [endoscopic] biopsy of biliary duct or sphincter of oddi diagnoses: unspecified pleural effusion unspecified essential hypertension other pulmonary insufficiency, not elsewhere classified iron deficiency anemia secondary to blood loss (chronic) other and unspecified hyperlipidemia anxiety state, unspecified pneumonitis due to inhalation of food or vomitus diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled personal history of venous thrombosis and embolism dehydration delirium due to conditions classified elsewhere acute pancreatitis pneumonia due to klebsiella pneumoniae cyst and pseudocyst of pancreas calculus of gallbladder without mention of cholecystitis, with obstruction mechanical complication of tracheostomy nonspecific abnormal results of function study of liver other protein-calorie malnutrition 

Answer: The patient is high likely exposed to